Cloudiness indicates peptide aggregation, bacterial contamination, or particulate matter from improper reconstitution technique
Probably not
How is AOD 9604 different from semaglutide
SLU-PP-332 is a novel synthetic pan-agonist of the estrogen-related receptors (ERR, ERR, ERR), originally developed at Saint Louis University and characterised in recent pre-clinical literature as an exercise mimetic. It is widely studied in research models exploring mitochondrial biogenesis, fatty-acid oxidation, and metabolic endurance
If you took too much, the kidneys removed it from the bloodstream in the urine
Potential candidates include people interested in improving mitochondrial function, supporting cognitive performance, or optimizing metabolic health